skip to Global Navigation Bar skip to main content

homeHome > About Us > Recruitment > News


News Content
Daewoong Pharmaceutical’s ‘Urusa 300mg’ secured application to ‘prevention of gallbladder stones after gastrectomy’ for the first time in the world.
Date 2019-05-29 Hit 831
News List
Prev Daewoong Pharmaceutical’s Botulinum Toxin officially released in the U.S... targeting the world’s largest Botulinum Toxin market.
Next A global symposium pays attention to Nav 1.7 Chronic Pain Treatment, DWP17061.